These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21388136)

  • 1. Pro-soft Val-boroPro: a strategy for enhancing in vivo performance of boronic acid inhibitors of serine proteases.
    Poplawski SE; Lai JH; Sanford DG; Sudmeier JL; Wu W; Bachovchin WW
    J Med Chem; 2011 Apr; 54(7):2022-8. PubMed ID: 21388136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.
    Connolly BA; Sanford DG; Chiluwal AK; Healey SE; Peters DE; Dimare MT; Wu W; Liu Y; Maw H; Zhou Y; Li Y; Jin Z; Sudmeier JL; Lai JH; Bachovchin WW
    J Med Chem; 2008 Oct; 51(19):6005-13. PubMed ID: 18783201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors.
    Milo LJ; Lai JH; Wu W; Liu Y; Maw H; Li Y; Jin Z; Shu Y; Poplawski SE; Wu Y; Sanford DG; Sudmeier JL; Bachovchin WW
    J Med Chem; 2011 Jul; 54(13):4365-77. PubMed ID: 21634429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides.
    Coutts SJ; Kelly TA; Snow RJ; Kennedy CA; Barton RW; Adams J; Krolikowski DA; Freeman DM; Campbell SJ; Ksiazek JF; Bachovchin WW
    J Med Chem; 1996 May; 39(10):2087-94. PubMed ID: 8642568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dipeptidyl peptidase IV (CD26) by peptide boronic acid dipeptides.
    Pargellis CA; Campbell SJ; Pav S; Graham ET; Pitner TP
    J Enzyme Inhib; 1997 Jan; 11(3):151-69. PubMed ID: 9204385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic acid-base equilibra of alanyl-boroAlanine.
    Lai JH; Zhou Y; Sudmeier JL; Wu W; Sanford DG; Hliang M; Poplawski S; Bachovchin WW
    Adv Exp Med Biol; 2003; 524():333-8. PubMed ID: 12675255
    [No Abstract]   [Full Text] [Related]  

  • 7. 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.
    Wu W; Liu Y; Milo LJ; Shu Y; Zhao P; Li Y; Woznica I; Yu G; Sanford DG; Zhou Y; Poplawski SE; Connolly BA; Sudmeier JL; Bachovchin WW; Lai JH
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5536-40. PubMed ID: 22853995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis.
    Okondo MC; Johnson DC; Sridharan R; Go EB; Chui AJ; Wang MS; Poplawski SE; Wu W; Liu Y; Lai JH; Sanford DG; Arciprete MO; Golub TR; Bachovchin WW; Bachovchin DA
    Nat Chem Biol; 2017 Jan; 13(1):46-53. PubMed ID: 27820798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous (19)F NMR screening of prolyl oligopeptidase and dipeptidyl peptidase IV inhibitors.
    Kichik N; Tarragó T; Giralt E
    Chembiochem; 2010 May; 11(8):1115-9. PubMed ID: 20397181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
    Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
    Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors.
    Matheeussen V; Lambeir AM; Jungraithmayr W; Gomez N; Mc Entee K; Van der Veken P; Scharpé S; De Meester I
    Clin Chim Acta; 2012 Feb; 413(3-4):456-62. PubMed ID: 22093941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
    Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
    Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.
    Flentke GR; Munoz E; Huber BT; Plaut AG; Kettner CA; Bachovchin WW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1556-9. PubMed ID: 1671716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs.
    Diez-Torrubia A; García-Aparicio C; Cabrera S; De Meester I; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2010 Jan; 53(2):559-72. PubMed ID: 20000418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).
    Gilmore BF; Lynas JF; Scott CJ; McGoohan C; Martin L; Walker B
    Biochem Biophys Res Commun; 2006 Jul; 346(2):436-46. PubMed ID: 16769036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors.
    Simpkins LM; Bolton S; Pi Z; Sutton JC; Kwon C; Zhao G; Magnin DR; Augeri DJ; Gungor T; Rotella DP; Sun Z; Liu Y; Slusarchyk WS; Marcinkeviciene J; Robertson JG; Wang A; Robl JA; Atwal KS; Zahler RL; Parker RA; Kirby MS; Hamann LG
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6476-80. PubMed ID: 17937986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site.
    Kühn-Wache K; Bär JW; Hoffmann T; Wolf R; Rahfeld JU; Demuth HU
    Biol Chem; 2011 Mar; 392(3):223-31. PubMed ID: 21284559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV.
    Tanaka S; Murakami T; Horikawa H; Sugiura M; Kawashima K; Sugita T
    Int J Immunopharmacol; 1997 Jan; 19(1):15-24. PubMed ID: 9226475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a Z-pro-prolinal-insensitive Z-Gly-Pro-7-amino-4-methyl coumarin-hydrolyzing peptidase from bovine serum--a new proline-specific peptidase.
    Birney YA; O'Connor BF
    Protein Expr Purif; 2001 Jul; 22(2):286-98. PubMed ID: 11437605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
    Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
    Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.